Clinical evidence

Clinical evaluation, investigations and post-market follow-up

Clinical evidence is the most common source of notified body questions and the most common weakness of reimbursement dossiers. We prepare clinical evaluations, design data collection that works for both regulators and payers, and run clinical investigations and post-market follow-up.

Clinical evaluation and CERIVD performance evaluationPMCF and PMPF studies

The core principle

One body of evidence, two audiences

The notified body asks whether the device is safe and performs as claimed. The payer asks whether it adds value over current practice. Different questions — but the answers can come from the same data collection, if it is designed with both in mind.

Tracking length of stay, downstream resource use or reintervention rates alongside safety endpoints rarely changes study cost materially. Adding them retrospectively is impossible.

Equivalence is not a shortcut

Basing a clinical evaluation on an equivalent device is legitimate, but MDR sets strict conditions — technical, biological and clinical characteristics must be comparable and the manufacturer needs sufficient access to the data. For higher classes this route is often not viable in practice.

FAQ

Questions we hear most

Answers reflect the rules and decision practice as of September 2026.

When is a clinical investigation required?

As a rule for implantable and class III devices, unless sufficient clinical data can be demonstrated another way — typically through equivalence or existing evidence for a device already on the market.

For lower classes a systematic review plus real-world data is often viable. Either way the reasoning belongs in the clinical evaluation plan, not in its conclusion.

How does IVD performance evaluation differ?

In vitro diagnostics require three distinct strands: scientific validity of the analyte, analytical performance and clinical performance. Each needs its own data and its own argument, and IVDR requires the structure explicitly.

Not sure your clinical data is enough?

We will review the intended purpose, the available evidence and the requirements for your class — and tell you what is missing.

Managing DirectorMartin Kolekmartin.kolek@ceeor.com+420 728 411 042
Regulatory AffairsIvana Kubátováivana.kubatova@ceeor.com+420 602 345 190